Understanding fragility fracture patients' decision-making process regarding bisphosphonate treatment

被引：20

作者：

Wozniak, L. A. ^{[1
,2
]}

Johnson, J. A. ^{[1
]}

McAlister, F. A. ^{[1
,2
]}

Beaupre, L. A. ^{[3
]}

Bellerose, D. ^{[2
]}

Rowe, B. H. ^{[1
,4
]}

Majumdar, S. R. ^{[1
,2
,5
]}

机构：

[1] Univ Alberta, Sch Publ Hlth, Li Ka Shing Ctr Hlth Res Innovat 2 040, Edmonton, AB T6G 2E1, Canada

[2] Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada

[3] Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, Edmonton, AB, Canada

[4] Univ Alberta, Fac Med & Dent, Dept Emergency Med, Edmonton, AB, Canada

[5] Univ Alberta, 5-134B Clinical Sci Bldg,11350-83rd Ave, Edmonton, AB T6G 2G3, Canada

来源：

OSTEOPOROSIS INTERNATIONAL | 2017年 / 28卷 / 01期

基金：

加拿大健康研究院;

关键词：

Adherence; Fragility fractures; Grounded theory; Osteoporosis; Persistence; Treatment; OSTEOPOROSIS TREATMENT; HIP FRACTURE; BONE HEALTH; MULTIFACETED INTERVENTION; SCREENING-PROGRAM; CONTROLLED-TRIAL; WRIST FRACTURE; CARE; IMPROVE; MANAGEMENT;

D O I：

10.1007/s00198-016-3693-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We aimed to understand how patients 50 years and older decided to persist with or stop osteoporosis (OP) treatment. Processes related to persisting with or stopping OP treatments are complex and dynamic. The severity and risks and harms related to untreated clinical OP and the favorable benefit-to-risk profile for OP treatments should be reinforced. Older adults with fragility fracture and clinical OP are at high risk of recurrent fracture, and treatment reduces this risk by 50 %. However, only 20 % of fracture patients are treated for OP and half stop treatment within 1 year. We aimed to understand how older patients with new fractures decided to persist with or stop OP treatment over 1 year. We conducted a grounded theory study of patients 50 years and older with upper extremity fracture who started bisphosphonates and then reported persisting with or stopping treatment at 1 year. We used theoretical sampling to identify patients who could inform emerging concepts until data saturation was achieved and analyzed these data using constant comparison. We conducted 21 interviews with 12 patients. Three major themes emerged. First, patients perceived OP was not a serious health condition and considered its impact negligible. Second, persisters and stoppers differed in weighting the risks vs benefits of treatments, where persisters perceived less risk and more benefit. Persisters considered treatment "required" while stoppers often deemed treatment "optional." Third, patients could change treatment status even 1-year post-fracture because they re-evaluated severity and impact of OP vs risks and benefits of treatments over time. The processes and reasoning related to persisting with or stopping OP treatments post-fracture are complex and dynamic. Our findings suggest two areas of leverage for healthcare providers to reinforce to improve persistence: (1) the severity and risks and harms related to untreated clinical OP and (2) the favorable benefit-to-risk profile for OP treatments.

引用

页码：219 / 229

页数：11

共 50 条

[11] Clinician's Guide to Prevention and Treatment of Osteoporosis [J].

Cosman, F. ;

de Beur, S. J. ;

LeBoff, M. S. ;

Lewiecki, E. M. ;

Tanner, B. ;

Randall, S. ;

Lindsay, R. .

OSTEOPOROSIS INTERNATIONAL, 2014, 25 (10) :2359-2381

[12] An Osteoporosis and Fracture Intervention Program Increases the Diagnosis and Treatment for Osteoporosis for Patients with Minimal Trauma Fractures [J].

Edwards, Beatrice J. ;

Bunta, Andrew D. ;

Madison, Laird D. ;

DeSantis, Anthony ;

Ramsey-Goldman, Rosalind ;

Taft, Lois ;

Wilson, Caroline ;

Moinfar, Maryam .

JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2005, 31 (05) :267-274

[13]

Fisher J. D., 2009, Emerging theories in health promotion practice and research, P21

[14] An information-motivation-behavioral skills model of adherence to antiretroviral therapy [J].

Fisher, Jeffrey D. ;

Fisher, William A. ;

Amico, K. Rivet ;

Harman, Jennifer J. .

HEALTH PSYCHOLOGY, 2006, 25 (04) :462-473

[15] Interventions to improve osteoporosis treatment following hip fracture - A prospective, randomized trial [J].

Gardner, MJ ;

Brophy, RH ;

Demetrakopoulos, D ;

Koob, J ;

Hong, R ;

Rana, A ;

Lin, JT ;

Lane, JM .

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2005, 87A (01) :3-7

[16]

Kalichman S C, 2001, J Assoc Nurses AIDS Care, V12, P58, DOI 10.1016/S1055-3290(06)60217-3

[17] Barriers and solutions to osteoporosis care in patients with a hip fracture [J].

Kaufman, JD ;

Bolander, ME ;

Bunta, AD ;

Edwards, BJ ;

Fitzpatrick, LA ;

Simonelli, C .

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2003, 85A (09) :1837-1843

[18] Long-term persistence with anti-osteoporosis drugs after fracture [J].

Klop, C. ;

Welsing, P. M. J. ;

Elders, P. J. M. ;

Overbeek, J. A. ;

Souverein, P. C. ;

Burden, A. M. ;

van Onzenoort, H. A. W. ;

Leufkens, H. G. M. ;

Bijlsma, J. W. J. ;

de Vries, F. .

OSTEOPOROSIS INTERNATIONAL, 2015, 26 (06) :1831-1840

[19]

Kolata G., 2016, NY TIMES, pA1

[20] A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis [J].

Little, Elizabeth A. ;

Eccles, Martin P. .

IMPLEMENTATION SCIENCE, 2010, 5

← 1 2 3 4 5 →